Reshma Rangwala - EVP & Chief Medical Officer at Karyopharm Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP & Chief Medical Officer
Stock Symbol
KPTI on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Reshma Rangwala since 4/23/2024

Holdings reported by Reshma Rangwala for Karyopharm Therapeutics Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 29.3K $18.4K $0.63 Mar 4, 2025 Direct
Stock Option (right to buy) 9.17K Feb 28, 2025 Direct Common Stock

Transactions reported by Reshma Rangwala for Karyopharm Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.